ASX - By Stock
|
OPL |
Re:
Opyl matters
|
|
MrSpecul8
|
11 |
2.6K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
11
|
2.6K
|
2
|
|
ASX - By Stock
|
OPL |
Re:
Opyl matters
|
|
MrSpecul8
|
11 |
2.6K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
11
|
2.6K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Opyl matters
|
|
MrSpecul8
|
11 |
2.6K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
11
|
2.6K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Opyl matters
|
|
MrSpecul8
|
11 |
2.6K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
11
|
2.6K
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Trading Halt
|
|
MrSpecul8
|
4 |
1.6K |
6 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
4
|
1.6K
|
6
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Investor Presentation
|
|
MrSpecul8
|
127 |
44K |
4 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
127
|
44K
|
4
|
|
ASX - By Stock
|
RNT |
Re:
Ann: Trading Halt
|
|
MrSpecul8
|
9 |
2.3K |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
9
|
2.3K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
(TGA) will permit the prescribing of MDMA 1st July
|
|
MrSpecul8
|
125 |
32K |
3 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
125
|
32K
|
3
|
|
ASX - By Stock
|
DCC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
MrSpecul8
|
4 |
2.2K |
5 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
4
|
2.2K
|
5
|
|
ASX - By Stock
|
NOV |
Re:
Ann: December Quarter Results Presentation
|
|
MrSpecul8
|
38 |
12K |
6 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
38
|
12K
|
6
|
|
ASX - By Stock
|
NOV |
Re:
Novatti - The $1 party
|
|
MrSpecul8
|
4.4K |
1.2M |
4 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
4.4K
|
1.2M
|
4
|
|
ASX - By Stock
|
NOV |
Re:
Novatti - The $1 party
|
|
MrSpecul8
|
4.4K |
1.2M |
6 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
4.4K
|
1.2M
|
6
|
|
ASX - By Stock
|
NOV |
Re:
Novatti - The $1 party
|
|
MrSpecul8
|
4.4K |
1.2M |
3 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
4.4K
|
1.2M
|
3
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Novatti to launch International Bank of Australia
|
|
MrSpecul8
|
92 |
28K |
3 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
92
|
28K
|
3
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Novatti to launch International Bank of Australia
|
|
MrSpecul8
|
92 |
28K |
1 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
92
|
28K
|
1
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Novatti to launch International Bank of Australia
|
|
MrSpecul8
|
92 |
28K |
1 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
92
|
28K
|
1
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Novatti to launch International Bank of Australia
|
|
MrSpecul8
|
92 |
28K |
1 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
92
|
28K
|
1
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Novatti to launch International Bank of Australia
|
|
MrSpecul8
|
92 |
28K |
4 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
92
|
28K
|
4
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Novatti to launch International Bank of Australia
|
|
MrSpecul8
|
92 |
28K |
2 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
92
|
28K
|
2
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Novatti to launch International Bank of Australia
|
|
MrSpecul8
|
92 |
28K |
0 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
92
|
28K
|
0
|
|
ASX - By Stock
|
NOV |
Re:
Ann: International Bank of Australia Presentation
|
|
MrSpecul8
|
26 |
11K |
18 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
26
|
11K
|
18
|
|
ASX - By Stock
|
FEX |
Re:
FEX Valuation
|
|
MrSpecul8
|
798 |
268K |
1 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
798
|
268K
|
1
|
|
ASX - By Stock
|
RNT |
Re:
Ann: Fully Underwritten Rights Issue To Accelerate RentPay
|
|
MrSpecul8
|
48 |
16K |
3 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
48
|
16K
|
3
|
|
ASX - By Stock
|
CBE |
Re:
Ann: Assay Results Confirm Significant Cu Mineralisation at Ngami
|
|
MrSpecul8
|
497 |
197K |
0 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
497
|
197K
|
0
|
|
ASX - By Stock
|
CBE Mining |
Re:
TA/CHART Thread
|
|
MrSpecul8
|
180 |
57K |
0 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
180
|
57K
|
0
|
|
ASX - By Stock
|
CBE Mining |
Re:
TA/CHART Thread
|
|
MrSpecul8
|
180 |
57K |
1 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
180
|
57K
|
1
|
|
ASX - By Stock
|
CBE Mining |
Re:
TA/CHART Thread
|
|
MrSpecul8
|
180 |
57K |
0 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
180
|
57K
|
0
|
|
ASX - By Stock
|
CBE Mining |
Re:
TA/CHART Thread
|
|
MrSpecul8
|
180 |
57K |
1 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
180
|
57K
|
1
|
|
ASX - By Stock
|
CBE Mining |
Re:
TA/CHART Thread
|
|
MrSpecul8
|
180 |
57K |
1 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
180
|
57K
|
1
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Change of Director's Interest Notice - Mr Tim Hannon
|
|
MrSpecul8
|
16 |
6.9K |
1 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
16
|
6.9K
|
1
|
|
ASX - By Stock
|
CBE |
Re:
What’s CBE Worth
|
|
MrSpecul8
|
1.0K |
382K |
7 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
1.0K
|
382K
|
7
|
|
ASX - By Stock
|
CBE |
Re:
What’s CBE Worth
|
|
MrSpecul8
|
1.0K |
382K |
2 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
1.0K
|
382K
|
2
|
|
ASX - By Stock
|
CBE |
Re:
What’s CBE Worth
|
|
MrSpecul8
|
1.0K |
382K |
1 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
1.0K
|
382K
|
1
|
|
ASX - By Stock
|
CBE |
Re:
Ann: Significant Further Copper Mineralisation Intersected
|
|
MrSpecul8
|
51 |
22K |
9 |
09/09/22 |
09/09/22 |
ASX - By Stock
|
51
|
22K
|
9
|
|
ASX - By Stock
|
PPL |
Re:
Ann: FY22 Results Presentation
|
|
MrSpecul8
|
30 |
17K |
1 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
30
|
17K
|
1
|
|
ASX - By Stock
|
CBE |
Re:
Open Price Tomorrow..
|
|
MrSpecul8
|
44 |
16K |
0 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
44
|
16K
|
0
|
|
ASX - By Stock
|
CBE |
Re:
Open Price Tomorrow..
|
|
MrSpecul8
|
44 |
16K |
4 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
44
|
16K
|
4
|
|
ASX - By Stock
|
PPL |
Re:
Ann: 39% revenue and 63% operating cash flow growth for FY22
|
|
MrSpecul8
|
21 |
11K |
1 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
21
|
11K
|
1
|
|
ASX - By Stock
|
DCC |
Re:
Ann: Appointment of Chief Executive Officer
|
|
MrSpecul8
|
38 |
19K |
4 |
17/07/22 |
17/07/22 |
ASX - By Stock
|
38
|
19K
|
4
|
|
ASX - By Stock
|
DCC |
Re:
Ann: Appointment of Chief Executive Officer
|
|
MrSpecul8
|
38 |
19K |
0 |
10/07/22 |
10/07/22 |
ASX - By Stock
|
38
|
19K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
MrSpecul8
|
94 |
27K |
1 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
94
|
27K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
MrSpecul8
|
94 |
27K |
3 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
94
|
27K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 Dosing to Complete for Phase 1 Clinical Trial
|
|
MrSpecul8
|
43 |
10K |
2 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
43
|
10K
|
2
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Q3 FY22 Business Update
|
|
MrSpecul8
|
13 |
6.9K |
8 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
13
|
6.9K
|
8
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Hydrix completes A$2.82M placement
|
|
MrSpecul8
|
31 |
13K |
0 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
31
|
13K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
MrSpecul8
|
530 |
150K |
0 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
530
|
150K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Recruitment commenced for EMD-RX5 Phase 1 Study
|
|
MrSpecul8
|
13 |
3.5K |
0 |
13/03/22 |
13/03/22 |
ASX - By Stock
|
13
|
3.5K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Recruitment commenced for EMD-RX5 Phase 1 Study
|
|
MrSpecul8
|
13 |
3.5K |
9 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
13
|
3.5K
|
9
|
|
ASX - By Stock
|
PPL |
Re:
Ann: H1 FY22 Results Presentation
|
|
MrSpecul8
|
26 |
15K |
1 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
26
|
15K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Hidden Gems Webinar Presentation
|
|
MrSpecul8
|
5 |
1.7K |
4 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
5
|
1.7K
|
4
|
|